KR20120074703A - Composition for oral care - Google Patents

Composition for oral care Download PDF

Info

Publication number
KR20120074703A
KR20120074703A KR1020100136623A KR20100136623A KR20120074703A KR 20120074703 A KR20120074703 A KR 20120074703A KR 1020100136623 A KR1020100136623 A KR 1020100136623A KR 20100136623 A KR20100136623 A KR 20100136623A KR 20120074703 A KR20120074703 A KR 20120074703A
Authority
KR
South Korea
Prior art keywords
extract
composition
mugwort
licorice
mixture
Prior art date
Application number
KR1020100136623A
Other languages
Korean (ko)
Inventor
장태숙
김승연
Original Assignee
재단법인 대구테크노파크
장태숙
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 대구테크노파크, 장태숙 filed Critical 재단법인 대구테크노파크
Priority to KR1020100136623A priority Critical patent/KR20120074703A/en
Publication of KR20120074703A publication Critical patent/KR20120074703A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/312Foods, ingredients or supplements having a functional effect on health having an effect on dental health
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: An oral composition containing a mixture of natural plant extracts is provided to remarkably improve anti-inflammatory and antibacterial effects. CONSTITUTION: A composition for dental care contains Artemisia princeps Pam.Var.orientlis Hara extract, Glycyrrhiza uralensis Fischer extract, Coptis japonica Makino extract, Forsythia suspensa Vahl extract, or a mixture thereof. Each extract is prepared using water, C1-C4 low carbon number alcohol or a mixture solvent thereof. The composition is manufactured in the form of toothpaste, oral cleanser, oral spray, or oral tissue. A health functional food for preventing and treating periodontal diseases contains the extract as an active ingredient. The health functional food is manufactured in the form of powder, granules, tablets, capsules, or beverage.

Description

구강 관리를 위한 조성물{COMPOSITION FOR ORAL CARE}Composition for oral care {COMPOSITION FOR ORAL CARE}

본 발명은 구강 관리를 위한 조성물에 관한 것으로, 한방 성분, 특히 쑥, 감초, 황련, 연교가 포함되어 항염, 항균 효능이 현저하게 향상된 조성물에 관한 것입니다.The present invention relates to a composition for oral care, including herbal ingredients, in particular mugwort, licorice, yellow lotus, yeonkyo, and relates to a composition with significantly improved anti-inflammatory and antibacterial efficacy.

치약은 일반적으로 연마제, 발포제, 습윤제, 결합제, 착향제 등을 포함하고 있으며, 불소 화합물을 추가로 포함함으로써 치아구조를 재 강화시키고 내산성을 향상시켜 우식균에 대한 치아의 저항력을 높일 수 있다. 20세 이상 성인의 경우에는 과반수 이상, 35세 이후에는 4명당 3명꼴, 그리고 40세 이상의 장노년층의 경우 80~90%에서 치주 질환이 발생한다. 이러한 치주 질환은 구강 내에 생존하는 200여종의 미생물 중 스타필로코커스 아우레우스(Staphylococcus aureus)을 비롯한 구강질환 유발균들이 생성하는 비수용성 글루칸과 미생물들 그리고 음식물 잔사 등이 서로 엉켜 치아의 표면에 치태라고 하는 치면세균막을 형성하는데, 이 치태의 독성세균이나 이들이 생산한 독소가 치주조직 내로 침입하여 치은의 염증, 치조골의 파괴 및 감염을 일으키면 치주병이 되며, 또한 이들 세균이 산(酸)을 생성하면 치아우식증의 원인이 된다.Toothpastes generally include abrasives, foaming agents, wetting agents, binders, flavoring agents, and the like, and further include fluorine compounds to reinforce tooth structure and improve acid resistance, thereby increasing tooth resistance to caries. Periodontal disease occurs in more than half of adults over 20 years of age, 3 in 4 people after 35 years of age, and 80-90% of older adults over 40 years of age. This periodontal disease is caused by entanglement of non-aqueous glucan, microorganisms and food residues produced by oral disease-causing bacteria including Staphylococcus aureus among 200 kinds of microorganisms living in the oral cavity. It forms a periodontal bacterial membrane, which is a periodontal disease when toxic bacteria or toxins produced by the plaque invade the periodontal tissue, causing inflammation of the gingiva, destruction of alveolar bone, and infection, and these bacteria produce acid. This can cause dental caries.

최근에, 이러한 치아 우식증을 포함하는 치주 질환을 예방하고 치료하기 위하여, 구강 내 세균에 대한 항균제 또는 항염제가 다양하게 개발되고 있다. 항균제의 예로는 bisbiguanides 제제, 4급 암모늄 제제 및 페놀 화합물 등이 있다. 그러나, 이러한 항균제는 화학적으로 합성된 것으로, 많은 부작용이 보고되고 있다.Recently, in order to prevent and treat periodontal diseases including such dental caries, various antibacterial or anti-inflammatory agents for oral bacteria have been developed. Examples of antibacterial agents include bisbiguanides preparations, quaternary ammonium preparations and phenolic compounds. However, these antimicrobial agents are chemically synthesized, and many side effects have been reported.

따라서, 최근에는 부작용이 적은 천연물 제제에 대한 연구가 증가되고 있으나, 사용자가 만족할 만한 항염, 항균 효과를 갖는 구강 관리용 치약 조성물이 개발되고 있지 않다.Therefore, in recent years, research on natural product formulations with fewer side effects has been increasing, but toothpaste compositions for oral care having anti-inflammatory and antimicrobial effects that are satisfactory for the user have not been developed.

따라서, 이러한 치주 질환, 치아 우식증 등을 예방 또는 치료하기 위해 항염, 항균 기능을 갖는 천연 소재가 함유된 구강 관리용 조성물의 개발이 요구되고 있다. Therefore, in order to prevent or treat such periodontal disease, dental caries, and the like, development of a composition for oral care containing natural materials having anti-inflammatory and antibacterial functions is required.

본 발명은 항염 작용 및 항균 작용이 현저히 향상된 구강 관리를 위한 조성물 및 건강 기능 식품을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a composition and health functional food for oral care with significantly improved anti-inflammatory and antimicrobial activity.

상기 목적을 달성하기 위해, 본 발명은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함하는 것을 특징으로 하는 구강 관리를 위한 조성물을 제공한다. In order to achieve the above object, the present invention provides a composition for oral care, comprising a mixture of mugwort extract, licorice extract, rhubarb extract, pontoon extract, or a mugwort extract, licorice extract, rhubarb extract and pontoon extract do.

또한, 본 발명은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 유효성분으로 포함하는 것을 특징으로 하는 충치 또는 치주 질환의 예방 및 개선용 건강 기능 식품을 제공한다.In addition, the present invention for the prevention and improvement of dental caries or periodontal disease, characterized in that it comprises a mixture of mugwort extract, licorice extract, rhubarb extract, yeonja extract, or mugwort extract, licorice extract, rhubarb extract and yeonja extract as an active ingredient Provide dietary supplements.

본 발명에 따른 구강 관리를 위한 조성물은 쑥, 감초, 황련, 연교 추출물을 포함함으로써, 항염, 항균 효능이 현저하게 향상된다.Composition for oral care according to the present invention includes the mugwort, licorice, yellow lotus, yeonja extract, anti-inflammatory, antimicrobial efficacy is significantly improved.

도 1은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 및 쑥/감초/황련/연교 추출물의 혼합물을 처리한 세포의 NO 생성을 나타낸다.
도 2는 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 및 쑥/감초/황련/연교 추출물의 혼합물을 처리한 세포의 생존능(viability)을 나타낸다.
도 3은 쑥 추출물(①), 감초 추출물(②), 황련 추출물(③), 연교 추출물(④), 및 쑥/감초/황련/연교 추출물의 혼합물(⑤)의 항균 활성을 나타낸다.
Figure 1 shows the NO production of cells treated with a mixture of mugwort extract, licorice extract, rhubarb extract, pontoon extract, and mugwort / licorice / strawberry / pontoon extract.
Figure 2 shows the viability of the cells treated with the mixture of mugwort extract, licorice extract, rhubarb extract, pontoon extract, and mugwort / licorice / rye / poncho extract.
Figure 3 shows the antimicrobial activity of the mugwort extract (①), licorice extract (②), rhubarb extract (③), pontoon extract (④), and the mixture (⑤) of the mugwort / licorice / rye / poncho extract.

본 발명은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함하는 것을 특징으로 하는 구강 관리를 위한 조성물에 관한 것이다. The present invention relates to a composition for oral care, characterized in that it comprises a mugwort extract, licorice extract, rhubarb extract, smoked extract, or a mixture of mugwort extract, licorice extract, rhubarb extract and smoked extract.

상기 쑥 추출물, 건조된 쑥 중량의 1 내지 10배, 바람직하게는 1 내지 5배 부피의 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매로부터 선택된 용매에 가용한 추출물로서, 바람직하게는 에탄올을 가하여 48 내지 96시간, 바람직하게는 72시간 동안 냉침 추출, 열수 추출, 초음파 추출, 환류냉각 추출, 바람직하게는 환류냉각 추출 후 여과 농축하여 동결건조하여 수득할 수 있다. As an extract available in a solvent selected from the mugwort extract, 1 to 10 times the weight of dried mugwort, preferably 1 to 5 times the volume of water, C 1 to C 4 lower alcohol or a mixed solvent thereof. It can be obtained by ethanol addition, cold condensation extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, preferably reflux cooling extraction, followed by filtration and drying for 48 to 96 hours, preferably 72 hours.

상기 구강 조성물은 치약, 구강청정제, 구강용 스프레이 또는 구강용 티슈 등의 제형으로 제조하여 사용될 수 있으나, 이에 한정되는 것은 아니다. The oral composition may be prepared by using a formulation such as toothpaste, mouthwash, mouth spray or mouth tissue, but is not limited thereto.

본 발명에 따른 구강관리를 위한 조성물은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물 각각을 포함하거나, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물, 또는 쑥, 감초, 황련 및 연교의 혼합 추출물을 유효 성분으로 포함할 수 있다. The composition for oral care according to the present invention comprises mugwort extract, licorice extract, rhubarb extract, and pontoon extract, respectively, or a mixture of mugwort extract, licorice extract, rhubarb extract and rhubarb extract, or of mugwort, licorice, rhubarb and britain Mixed extracts may be included as active ingredients.

바람직하게는, 본 발명에 따른 구강 관리를 위한 조성물은 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함한다. Preferably, the composition for oral care according to the present invention comprises a mixture of mugwort extract, licorice extract, rhubarb extract and duct extract.

또한, 본 발명에 따른 구강 관리를 위한 조성물이 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함하는 경우, 각 추출물의 조성비는 쑥 추출물 100 중량부에 대하여, 감초 추출물은 0.1 내지 100 중량부; 황련 추출물은 0.1 내지 100 중량부; 및 연교 추출물 0.1 내지 100 중량부를 포함한다.In addition, when the composition for oral care according to the present invention comprises a mixture of mugwort extract, licorice extract, rhubarb extract and duct extract, the composition ratio of each extract is based on 100 parts by weight of mugwort extract, the licorice extract is 0.1 to 100 weight part; Rhubarb extract is 0.1 to 100 parts by weight; And 0.1 to 100 parts by weight smoked extract.

본 발명에 따른 구강 관리를 위한 조성물이 치약으로 사용되는 경우에는 치약을 제조하는 데 필요한 통상적인 성분들로서, 연마제, 발포제, 습윤제, 결합제 등을 포함할 수 있다. When the composition for oral care according to the present invention is used as a toothpaste, conventional components required for preparing the toothpaste may include an abrasive, a foaming agent, a humectant, a binder, and the like.

연마제는 치아 표면의 치석을 제거하고 표면의 광택을 만들어 주는 기능을 하며, 침강산나트륨, 피로인산나트륨, 불용성 메타인산나트륨, 인신일수소칼륨, 인산화규소, 침강탄산칼슘 등을 사용할 수 있고, 발포제로는 라우릴황산나트륨, 비이온성 계면활성제인 폴리옥시에틸렌/폴리옥시프로필렌의 공중합체, 폴리옥시에틸렌 경화 피마자유, 폴리옥시에틸렌솔비탄 지방산에스테르 등이 사용할 수 있고, 습윤제로는 글리세린, 솔비톨, 프로필렌글리콜 등이 사용할 수 있으며, 결합제로는 카르복시메틸셀룰로오스나트륨, 카보머, 카라기난, 잔탄검, 알지네이트류 등을 사용할 수 있으나, 이에 한정되는 것은 아니다.Abrasive removes tartar on the surface of teeth and makes surface gloss. Sodium precipitate, sodium pyrophosphate, insoluble sodium metaphosphate, potassium monohydrogen phosphorus, silicon phosphate, precipitated calcium carbonate, etc. can be used. Examples thereof include sodium lauryl sulfate, copolymers of polyoxyethylene / polyoxypropylene which are nonionic surfactants, polyoxyethylene hardened castor oil, polyoxyethylene sorbitan fatty acid esters, and the like. Glycol, and the like, and as the binder, carboxymethylcellulose sodium, carbomer, carrageenan, xanthan gum, alginates, and the like may be used, but is not limited thereto.

본 발명에 따른 구강 관리를 위한 조성물은 추가로 맨톨(Mentol), 아네톨(Anetol), 오이게놀(Eugenol), 리모넨(Limonene), 오시멘(Ocimene), n-도데실알콜(n-Dodecyl Alcohol), 시트로네놀(Citronenol), 알파터피네올(a-Terpineol), 살리실메틸(Methyl salycilate), 메틸아세테이트(Methyl Acetate), 시트로네릴 아세테이트(Citronelyl Acetate), 시네올(Cineol), 리나롤(Linalool), 에틸리나롤(Ethyl Linalool), 바닐린(Vanillin), 티몰(Thymol), 스피아민트(Spearmint)유, 세지(Sage)유, 로즈마리(Rosemary)유, 계피(Cinamon)유 등의 향료를 단독 또는 조합하여 전체의 0.1-10중량%, 바람직하게는 0.5-5중량%의 양으로 배합하여 사용할 수 있다.
The composition for oral care according to the present invention is additionally Menthol, Anetol, Eugenol, Limonene, Limonene, Ocimene, n-dodecyl alcohol. Alcohol, Citronenol, Alpha-Terpineol, Methyl salycilate, Methyl Acetate, Citroneryl Acetate, Cineol, Linalol, Ethyl Linalool, Vanillin, Thymol, Spearmint Oil, Sage Oil, Rosemary Oil, Cinnamon Oil, etc. Perfumes may be used alone or in combination in amounts of 0.1-10% by weight, preferably 0.5-5% by weight.

한편, 본 발명에 따른 구강 관리를 위한 조성물은 하이드록시아파타이트를 추가로 포함함으로써 미백효과를 가질 수 있다.
On the other hand, the composition for oral care according to the present invention may have a whitening effect by further comprising hydroxyapatite.

또한, 본 발명은 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 유효성분으로 함유하는 치주질환의 예방 및 개선용 건강 기능 식품을 제공한다. In another aspect, the present invention provides a health functional food for the prevention and improvement of periodontal disease containing mugwort extract, licorice extract, rhubarb extract, pontoon extract, or a mixture of mugwort extract, licorice extract, rhubarb extract and poncho extract as an active ingredient. .

본 발명에 따른 건강 기능 식품은 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다. The health functional food according to the present invention can be used in the form of a powder, granule, tablet, capsule or beverage.

본 발명에 따른 건강 기능 식품은 치주질환 예방 및 개선을 위한 약제, 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명에 따른 건강 기능 식품으로는, 예를 들어 각종 식품류, 음료, 껌, 차, 비타민 복합체, 건강보조 식품류 등이 있다. 식품 또는 음료 중의 상기 유효 성분의 양은 일반적으로 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물은 100 ml을 기준으로 0.02 내지 10 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다.Health functional food according to the present invention can be used in a variety of drugs, foods and drinks for preventing and improving periodontal disease. The health functional food according to the present invention includes, for example, various foods, beverages, gums, teas, vitamin complexes, and health supplements. The amount of the active ingredient in the food or beverage may generally be added at 0.01 to 15% by weight of the total food weight, and the health beverage composition may be added at a rate of 0.02 to 10 g, preferably 0.3 to 1 g based on 100 ml. Can be.

본 발명의 건강 기능 식품은 지시된 비율로 필수 성분으로서 상기 유효성분을 함유하는 것 외에 특별한 제한점은 없으며, 통상의 식품과 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.
The health functional food of the present invention has no special limitation other than the above-mentioned active ingredient as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates, etc. as additional ingredients as usual food.

이하, 본 발명을 하기 실시예 및 실험예에 의해 상세히 설명한다. Hereinafter, the present invention will be described in detail with reference to the following examples and experimental examples.

단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.
However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.

실시예 1. 추출물의 제조Example 1 Preparation of Extract

추출 방법을 아래와 같은 정도로 기재해 주세요.Please list extraction method as follows.

본 실험에 사용된 쑥(Artemisia princeps Pam.Var.orientlis Hara), 감초(Glycyrrhiza uralensis Fischer), 황련(Coptis japonica Makino), 연교 (Forsythia suspensa Vahl)은 약업사에서 구입하여 물로 세척하여 음건 후, 건조중량 100g을 취하여 50% 에탄올에 담궈 72 시간 동안 환류냉각 추출하였다. 이후 여과 농축하여 동결 건조하여 쑥 추출물(수율 18.6%), 감초 추출물(수율 21.2%), 황련 추출물(수율 19.8%), 연교 추출물(수율 17.6%)을 수득하였고, 증류수에 녹여 0.2 um 필터(Millipore Corporation, Bedford, MA, 미국)로 여과하여 하기 실험예의 시료로 사용하였다.
Artemisia princeps Pam.Var.orientlis Hara, Glycyrrhiza uralensis Fischer , Coptis japonica Makino and Forsythia suspensa Vahl used in this experiment were purchased from pharmacists, washed with water, dried and dried 100 g was taken in 50% ethanol and reflux cooled for 72 hours. Thereafter, the filtrate was concentrated and freeze-dried to obtain a mugwort extract (yield 18.6%), licorice extract (yield 21.2%), rhubarb extract (yield 19.8%), pontoon extract (yield 17.6%), and dissolved in distilled water, 0.2 um filter (Millipore). Corporation, Bedford, MA, USA) was used as a sample of the following experimental example.

참고예 1. 실험균주 및 배양Reference Example 1. Experimental strain and culture

(1) 항염 시험을 위한 세포주로는 마우스 마크로파지의 RAW264.7를 사용하여, 5% 불활성화시킨 소 태아 혈청(FBS), 젠타마이신(gentamicin) 50㎍/㎖를 첨가한 DMEM(Dulbecco's modified Eagle's medium) 배지에서 37℃, 5%의 CO2 배양기에서 배양하였다.
(1) As cell lines for anti-inflammatory test, DMEM (Dulbecco's modified Eagle's medium) added 50 µg / ml of fetal bovine serum (FBS) and gentamicin (5% inactivated) using mouse macrophages RAW264.7 ) In culture at 37 ° C., 5% CO 2 incubator.

(2) 항균 시험을 위한 균주로는 스타필로코커스 아우레우스(Staphylococcus aureus(KCTC 1621, 한국 생명공학연구원 미생물자원센터)를 영양 배지(0.3% Beef extract, 0.5% 펩톤, pH 6.8, Becton, Dickinson and Company, USA)을 사용하여 배양하였다. 균주 스탁을 영양 배지에 접종한 다음, 37℃에서 24시간 동안 전배양하여 활성화시킨 다음, 균주를 회수하고 멸균수로 3회 세척한 후 준비하였다.
(2) As a strain for the antibacterial test, Staphylococcus aureus (KCTC 1621, Korea Research Institute of Biotechnology and Microbial Resources Center) was added to a nutrient medium (0.3% Beef extract, 0.5% peptone, pH 6.8, Becton, Dickinson). and Company, USA.) Strain stocks were inoculated into nutrient media, then activated by preculture at 37 ° C. for 24 hours, and then the strains were recovered, washed three times with sterile water and prepared.

실험예 1. 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물 및 쑥/감초/황련/연교 추출물의 혼합물의 항염 효과 측정Experimental Example 1. Determination of the anti-inflammatory effect of a mixture of mugwort extract, licorice extract, rhubarb extract, yeonja extract and mugwort / licorice / rye / yeonja extract

(1) 일산화질소(nitric oxide; NO) 함량 측정(1) Determination of nitric oxide (NO) content

일산화질소(nitric oxide; NO)의 양은 그리스 시약(Griess reagent)을 사용하여 측정하였다. 참고예 1.(1)에서 배양시킨 세포 (96구판에 8 X 104세포/구)에 대장균 지질다당체(E.Coli serotype 055:B5, Sigma-Aldrich, Stt. Louis, MO로부터 구입)의 농도가 100ng/ml가 되도록 하여 각 추출물의 농도가 0.1mg/ml, 0.5mg/ml, 1.0mg/ml가 되도록 처리하고, 24시간 후 배양 상층액에서 50㎕을 채취하여 50㎕의 그리스 시약(Griess reagent)(1% 설파닐아미드/0.1% 나프틸에틸렌 디아민 디하이드로클로라이드/2% 인산)과 96-웰 플레이트에서 혼합한 뒤 540nm에서 마이크로플레이트 리더로 흡광도(OD)값을 측정하였다. The amount of nitric oxide (NO) was measured using a Greries reagent. Reference Example 1 Concentration of E. coli lipopolysaccharide (purchased from E. Coli serotype 055: B5, Sigma-Aldrich, Stt. Louis, MO) on cells cultured in (1) (8 × 10 4 cells / sphere on 96 plate) Is 100ng / ml so that the concentration of each extract is 0.1mg / ml, 0.5mg / ml, 1.0mg / ml. After 24 hours, 50µl of the culture supernatant is collected and 50µl of grease reagent (Griess After mixing in a reagent) (1% sulfanylamide / 0.1% naphthylethylene diamine dihydrochloride / 2% phosphoric acid) in a 96-well plate, the absorbance (OD) value was measured with a microplate reader at 540 nm.

시료의 이산화질소 이온(NO2)(아질산이온 NO2 -)의 농도는 질산나트륨(NaNO2) 표준곡선을 이용하여 정량화하였다. The concentration of nitrogen dioxide ions (NO 2 ) (nitrite ion NO 2 ) in the sample was quantified using a sodium nitrate (NaNO 2) standard curve.

그 결과, 쑥, 감초, 황련, 연교 각각의 단일 추출물과, 쑥/감초/황련/연교 추출물의 혼합물은 모두 농도 의존적으로 활성화된 RAW264.7 세포에서의 NO 생성을 억제함을 확인할 수 있었다. As a result, it was confirmed that the mixture of each of the single extracts of mugwort, licorice, yellow lotus, and pontoon and the extract of mugwort, licorice, yellow lotus, and pontoon all inhibit NO production in the RAW264.7 cells activated in a concentration-dependent manner.

쑥 단일 추출물, 감초 단일 추출물, 황련 단일 추출물, 연교 단일 추출물 및 쑥/감초/황련/연교 추출물의 혼합물의 각 농도에서, 지질다당질에 의해 유도되는 NO의 생성을 억제하였다(도 1 참조). At each concentration of the mixture of mugwort single extract, licorice single extract, rhubarb single extract, soft bristle single extract, and mugwort / licorice / rhubarb / brittle extract, the production of NO induced by lipopolysaccharide was inhibited (see FIG. 1).

하기 표 1은 추출물의 농도에 따른 NO 생성 억제율을 나타내는 것으로, 이는 동일한 방법으로 3회 시험한 결과의 평균값을 나타낸 것이다.Table 1 shows the NO production inhibition rate according to the concentration of the extract, which shows the average value of the results of three tests in the same manner.

농도
추출물
density
extract
0.1 mg/ml0.1 mg / ml 0.5 mg/ml0.5 mg / ml 1.0 mg/ml1.0 mg / ml
Mugwort 40 %40% 64 %64% 77 %77% 감초licorice 35 %35% 61 %61% 74 %74% 황련goldthread 29 %29% 47 %47% 69 %69% 연교Fellowship 37 %37% 63 %63% 76 %76% 쑥/감초/황련/연교Mugwort 37 %37% 63 %63% 73 %73%

(2) 세포 생존력(viability) 측정 (MTT assay)(2) cell viability measurement (MTT assay)

세포를 96-웰 플레이트에 분주한 다음, 각 추출물의 농도가 0.1mg/ml, 0.5mg/ml, 1.0mg/ml가 되도록 처리한 다음, 24시간 동안 반응시켰다. 그런 다음, 배양액을 제거하고, MTT 용액 (3-[4,5-디메틸티아졸-2-일]-2,5-디페닐테트라졸리움 브로마이드; 0.5 mg/ml)을 30㎕씩 첨가하여 37℃에서 2시간 동안 CO2 배양기에서 반응시켜 불용성의 포마잔 결정을 생성시겼다. The cells were dispensed into 96-well plates, treated with concentrations of 0.1 mg / ml, 0.5 mg / ml, and 1.0 mg / ml for each extract, followed by reaction for 24 hours. Then, the culture medium was removed, and 30 占 폚 of MTT solution (3- [4,5-dimethylthiazol-2-yl] -2,5-diphenyltetrazolium bromide; 0.5 mg / ml) was added at 37 占 폚. Incubated for 2 hours in a CO 2 incubator to produce insoluble formazan crystals.

이렇게 생성된 불용성 결정을 디메틸설폭시드(DMSO)로 완전히 녹인 다음, 마이크로플레이트 리더를 이용하여 570 nm의 파장에서 흡광도 값을 측정하였다. 이렇게 측정된 값을 이용하여 세포독성을 확인하였다.The insoluble crystal thus produced was completely dissolved in dimethyl sulfoxide (DMSO), and then absorbance values were measured at a wavelength of 570 nm using a microplate reader. The cytotoxicity was confirmed using the measured value.

그 결과, 도 2에서 보는 바와 같이 상기 추출물들은 세포 생존력에 영향을 미치지 않음을 확인하였다.
As a result, as shown in Figure 2 it was confirmed that the extract does not affect the cell viability.

실험예 2. 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 및 쑥/감초/황련/연교 추출물의 혼합물의 치주질환 원인균 증식 억제 효과 측정Experimental Example 2. Measurement of the inhibitory effect of periodontal disease-causing bacteria of the mixture of mugwort extract, licorice extract, rhubarb extract, pontoon extract, and mugwort

상기 실시예 1의 쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물 및 쑥/감초/황련/연교 추출물(1:1:1:1)의 혼합물의 치주질환 원인균인 스타필로코커스 아우레우스의 생육 저해 정도로 항균 효과를 측정하였다. Inhibition of growth of Staphylococcus aureus, the cause of periodontal disease of the mixture of mugwort extract, licorice extract, rhubarb extract, yeonja extract and mugwort / licorice / rye / yeonja extract of Example 1 The antimicrobial effect was measured to the extent.

하기 실험에서, 상기 추출물 각각 또는 상기 추출물의 혼합물은 각각 0.5g/ml의 농도로 사용하였다.In the following experiments, each of the extracts or a mixture of the extracts was used at a concentration of 0.5 g / ml each.

한천평판확산법 (Agar Diffusion Method)에 의한 생육저지환을 측정하기 위하여 Nutrient agar plate를 사용하였다. 균주는 37℃, 24시간 동안 전 배양하여 활성화 시킨 후 회수하여 멸균수로 3회 세척하여 준비하였다. 분광광도계를 사용하여 550nm에서 흡광도를 측정하여 1.5(± 0.5)x107 cells/㎖로 균수를 조정한 다음, 45℃로 유지된 탑 아가(top agar) 5㎖에 100㎕씩 가하여 잘 혼합한 후, Nutrient agar plate를 제조하였다. 각 추출물은 10mg/20㎕의 농도로 준비하여 6mm 직경의 종이 디스크(paper disc)위에 20㎕씩 적신 후, BSC (Biological Safety Cabinet, Labconco, USA) 안에서 완전히 건조시켜 사용하였다. 탑 아가 (top agar)가 마른 후에 Nutrient agar plate위에 각 추출물을 적셔, 건조시킨 디스크를 올리고 호기 조건, 37℃에서 배양하였다. 24시간 배양 후에 생성된 생육저지환은 vernier calipers (Mitutoyo, Japan)를 이용하여 측정하였다. 실험은 3회 반복하였으며, 아래 표 2는 생육저해환을 이용한 추출물의 항균력을 나타내는 것으로, 생육저해환의 직경을 평균값 ± 표준편차로 나타내었다. Nutrient agar plates were used to measure growth-lowering ring by the Agar Diffusion Method. The strain was prepared by activating after pre-culture at 37 ° C. for 24 hours, washing and rinsing three times with sterile water. Measure the absorbance at 550nm using a spectrophotometer, adjust the bacterial count to 1.5 (± 0.5) x10 7 cells / ml, mix well by adding 100µl to 5ml of top agar maintained at 45 ℃. , Nutrient agar plate was prepared. Each extract was prepared at a concentration of 10 mg / 20 μl, soaked 20 μl on a 6 mm diameter paper disc, and completely dried in BSC (Biological Safety Cabinet, Labconco, USA). After the top agar was dried, each extract was wetted on a Nutrient agar plate, and the dried disk was raised and incubated at 37 ° C. under aerobic conditions. Growth hypotermination produced after 24 hours of cultivation was measured using vernier calipers (Mitutoyo, Japan). The experiment was repeated three times, Table 2 below shows the antimicrobial activity of the extract using growth inhibition ring, the diameter of the growth inhibition ring is expressed as the average value ± standard deviation.

번호 number 추출물extract Clear Zone(mm)Clear Zone (mm) 1One Mugwort 13.3 ± 2.513.3 ± 2.5 22 감초licorice 23.3 ± 1.223.3 ± 1.2 33 황련goldthread 35.3 ± 2.335.3 ± 2.3 44 연교 Fellowship 20.3 ± 0.620.3 ± 0.6 55 쑥, 감초, 황련, 연교 (혼합시료)Mugwort, licorice, yellow lotus, yeonkyo (mixed sample) 12.0 ± 1.712.0 ± 1.7

따라서, 상기 추출물은 치주질환 원인균인 스타필로코커스 아우레우스에 대한 항균 효과를 갖고 있음을 확인할 수 있었다(도 3 참조).
Thus, the extract was confirmed to have an antimicrobial effect against Staphylococcus aureus, the causative agent of periodontal disease (see Figure 3).

제조예 1. 본 발명에 따른 구강관리를 위한 치약의 제조예Preparation Example 1 Preparation Example of Toothpaste for Oral Care According to the Present Invention

하기 표 3과 같은 조성 성분과 조성비에 따라 본 발명에 따른 조성물을 이용하여 치약을 제조할 수 있다.Toothpaste may be prepared using the composition according to the present invention according to the compositional components and composition ratios as shown in Table 3 below.

조성성분Ingredient 조성비(%)Composition ratio (%) 1One 주성분chief ingredient 플루오르화나트륨Sodium fluoride 0.10 % 0.10% 22 주성분chief ingredient 알란토인Allantoin 0.05 % 0.05% 33 계면활성제Surfactants 라우릴황산나트륨Sodium Lauryl Sulfate 2.50 % 2.50% 44 감미제Sweetener 삭카린나트륨(식용성)Zaccarin Sodium (Edible) 0.50 % 0.50% 55 감미제Sweetener 자일리톨Xylitol 1.00 % 1.00% 66 착향제Flavoring agent 감초 추출물Licorice extract 0.10 % 0.10% 77 착향제Flavoring agent 쑥 추출물Wormwood Extract 0.10 % 0.10% 88 착향제Flavoring agent 황련 추출물Rhubarb extract 0.10 % 0.10% 99 착향제Flavoring agent 연교 추출물Duct extract 0.10%0.10% 1010 착향제Flavoring agent 조합향료(애플민트향HF-60931)Combination fragrance (apple mint flavor HF-60931) 2.00 % 2.00% 1111 증백제Brightener 하이드록시아파타이트Hydroxyapatite 0.50 % 0.50% 1212 보존제Preservative 메틸파라벤Methyl paraben 0.10 % 0.10% 1313 용제solvent 에탄올ethanol 2.00 % 2.00% 1414 용제solvent 정제수Purified water 90.95 %90.95%

제조예 2. 건강 기능 식품의 제조예 Preparation Example 2 Preparation Example of Health Functional Food

- 쑥, 감초, 황련 및 연교 추출물(1:1:1:1)의 혼합물 1000 ㎎ - Artemisia, licorice, and yeongyo goldthread extract (1: 1: 1: 1) mixture of 1000 ㎎

- 비타민 혼합물 적량 - proper amount Vitamin mixture

- 비타민 A 아세테이트 70 ㎍ - Vitamin A acetate 70 ㎍

- 비타민 E 1.0 ㎎ - Vitamin E 1.0 ㎎

- 비타민 B1 0.13 ㎎ - Vitamin B1 0.13 ㎎

- 비타민 B2 0.15 ㎎ - Vitamin B2 0.15 ㎎

- 비타민 B6 0.5 ㎎ - vitamin B6 0.5 ㎎

- 비타민 B12 0.2 ㎍ - Vitamin B12 0.2 ㎍

- 비타민 C 10 ㎎ - vitamin C 10 ㎎

- 비오틴 10 ㎍ - Biotin 10 ㎍

- 니코틴산아미드 1.7 ㎎ - Nicotinic acid amide 1.7 ㎎

- 엽산 50 ㎍ - Folic Acid 50 ㎍

- 판토텐산 칼슘 0.5 ㎎ - Calcium Pantothenate 0.5 ㎎

- 무기질 혼합물 적량 - inorganic mixture proper quantity

- 황산제1철 1.75 ㎎ - ferrous sulfate 1.75 ㎎

- 산화아연 0.82 ㎎ - zinc oxide 0.82 ㎎

- 탄산마그네슘 25.3 ㎎ - magnesium carbonate 25.3 ㎎

- 제1인산칼륨 15 ㎎ - first potassium phosphate 15 ㎎

- 제2인산칼슘 55 ㎎ - a second calcium phosphate 55 ㎎

- 구연산칼륨 90 ㎎ - potassium citrate 90 ㎎

- 탄산칼슘 100 ㎎ - 100 ㎎ calcium carbonate

- 염화마그네슘 24.8 ㎎
- magnesium chloride 24.8 ㎎

상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강기능 식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.
Although the composition ratio of the above-mentioned vitamin and mineral mixtures is mixed with a component suitable for a health functional food in a preferred embodiment, the composition ratio may be arbitrarily modified, and the above components may be mixed according to a conventional health food manufacturing method. Next, the granules may be prepared and used for preparing the nutraceutical composition according to a conventional method.

제조예 3. 건강 음료의 제조예Preparation Example 3 Preparation Example of Healthy Drink

- 쑥, 감초, 황련 및 연교 추출물(1:1:1:1)의 혼합물 1000 ㎎ - Artemisia, licorice, and yeongyo goldthread extract (1: 1: 1: 1) mixture of 1000 ㎎

- 구연산 1000 ㎎ - Citric acid 1000 ㎎

- 올리고당 100 g - oligosaccharide 100 g

- 매실농축액 2 g - Japanese apricot concentrate 2 g

- 타우린 1 g - taurine 1 g

- 정제수를 가하여 전체 900 ㎖
- Purified water was added to total 900 ㎖

통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2ℓ 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. The above components were mixed according to a conventional health drink manufacturing method, and the mixture was heated at 85 DEG C for about 1 hour with stirring, and the solution thus prepared was filtered to obtain a sterilized 2-liter container, which was sealed and sterilized, ≪ / RTI >

상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다. Although the composition ratio is a mixture of the components suitable for the preferred beverage as a preferred embodiment, the blending ratio may be arbitrarily varied according to the regional and national preferences such as the demand level, the demanding country, and the intended use.

Claims (7)

쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함하는 것을 특징으로 하는 구강 관리를 위한 조성물.Mugwort extract, licorice extract, rhubarb extract, smoked extract, or a composition for oral care, characterized in that it comprises a mixture of mugwort extract, licorice extract, rhubarb extract and smoked extract. 제 1 항에 있어서,
상기 추출물 각각은 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매로부터 선택된 용매에 가용한 추출물인 것을 특징으로 하는 구강 관리를 위한 조성물.
The method of claim 1,
Each of the extract is a composition for oral care, characterized in that the extract available in a solvent selected from water, C 1 to C 4 lower alcohol or a mixed solvent thereof.
제 2 항에 있어서,
상기 추출물 각각은 에탄올에 가용한 추출물인 것을 특징으로 하는 구강 관리를 위한 조성물.
The method of claim 2,
Each of the extract is a composition for oral care, characterized in that the extract available in ethanol.
제 1 항에 있어서,
상기 구강 관리를 위한 조성물은 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 포함하며, 이 때 상기 쑥 추출물 100 중량부에 대하여:
상기 감초 추출물은 0.1 내지 100 중량부;
상기 황련 추출물은 0.1 내지 100 중량부; 및
상기 연교 추출물은 0.1 내지 100 중량부
를 포함하는 것을 특징으로 하는 구강 관리를 위한 조성물.
The method of claim 1,
The composition for the oral care comprises a mixture of mugwort extract, licorice extract, rhubarb extract and duct extract, wherein about 100 parts by weight of the mugwort extract:
The licorice extract is 0.1 to 100 parts by weight;
The sulfur extract is 0.1 to 100 parts by weight; And
The smoked extract is 0.1 to 100 parts by weight
Composition for oral care comprising a.
제 1 항 내지 제 4 항 중 어느 한 항에 있어서,
상기 구강 관리를 위한 조성물은 치약, 구강청정제, 구강용 스프레이 또는 구강용 티슈 제형인 것을 특징으로 하는 구강 관리를 위한 조성물.
The method according to any one of claims 1 to 4,
The composition for oral care is a composition for oral care, characterized in that the toothpaste, mouthwash, oral spray or oral tissue formulation.
쑥 추출물, 감초 추출물, 황련 추출물, 연교 추출물, 또는 쑥 추출물, 감초 추출물, 황련 추출물 및 연교 추출물의 혼합물을 유효성분으로 포함하는 것을 특징으로 하는 치주 질환의 예방 및 개선용 건강 기능 식품.Mugwort extract, licorice extract, rhubarb extract, smoked extract, or health functional food for the prevention and improvement of periodontal disease, characterized in that it comprises a mixture of mugwort extract, licorice extract, rhubarb extract and smoked extract as an active ingredient. 제 6 항에 있어서,
그 제형이 분말, 과립, 정제, 캡슐 또는 음료인 것을 특징으로 하는 건강 기능 식품.
The method according to claim 6,
A dietary supplement, characterized in that the formulation is a powder, granule, tablet, capsule or beverage.
KR1020100136623A 2010-12-28 2010-12-28 Composition for oral care KR20120074703A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100136623A KR20120074703A (en) 2010-12-28 2010-12-28 Composition for oral care

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100136623A KR20120074703A (en) 2010-12-28 2010-12-28 Composition for oral care

Publications (1)

Publication Number Publication Date
KR20120074703A true KR20120074703A (en) 2012-07-06

Family

ID=46708788

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100136623A KR20120074703A (en) 2010-12-28 2010-12-28 Composition for oral care

Country Status (1)

Country Link
KR (1) KR20120074703A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108310063A (en) * 2018-03-23 2018-07-24 何泽国 A kind of composition and products thereof for treating angular stomatitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108310063A (en) * 2018-03-23 2018-07-24 何泽国 A kind of composition and products thereof for treating angular stomatitis

Similar Documents

Publication Publication Date Title
Forouzanfar Review of the therapeutic effects of Camellia sinensis (green tea) on oral and periodontal health
Wu et al. Tea as a functional food for oral health
KR101723588B1 (en) Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof
KR101467316B1 (en) Oral cleansing composition fermented taraxacum extract-containing complex herbal extract
US20150017108A1 (en) Method of inhibiting the formation of dental plaque
CN102858308A (en) Toothpaste composition for tooth health
KR20170141053A (en) Composition for prevention or treatment of dental disease comprising an extract of Gardenia jasminoides
KR20160090956A (en) Composition for sanitation promotion of oral cavity comprising natural medicinal ingredient extract as effective component for halitosis inducing microoranism and infectious disease of mucous membrane
KR20120074717A (en) Composition for oral care
KR100999597B1 (en) A composition comprising an extract of Corydalis turtschaninovii or dehydrocorydaline isolated therefrom for preventing and treating dental caries
KR102438800B1 (en) Composition comtaining lactic acid fermented noni extract as active ingredient for prevention or treatment of oral disease
KR102572961B1 (en) Compositions for preventing, improving or treating periodontal disease containing dendropanax morbifera lev. extracts
KR20120074703A (en) Composition for oral care
KR101756306B1 (en) Oral composition containing extract of sapindus mukurossi Gaertn
KR20180118994A (en) Composition for preventing or alleviating or treating dental caries or periodontal disease by growth of oral pathogen
Nair et al. Green tea: a friendly oral beverage
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR102632336B1 (en) Composition for prevention or treatment of dental disease comprising an extract of Daphne genkwa
Nandan et al. Effect of green tea as a mouth rinse on Streptococcus mutans
KR101025886B1 (en) Oral care compositions containing Alismae Rhizoma extract for preventing tooth decay
Al-Ezzi et al. Black and green tea antimicrobial effect on Mutans streptococci and Lactobacilli.
KR102632335B1 (en) Composition for prevention or treatment of dental disease comprising anemarrhena extract
KR102642553B1 (en) Composition for prevention or treatment of dental disease comprising neomangiferin
KR102631909B1 (en) Composition for prevention or treatment of dental disease comprising hydroxygenkwanin
KR102642552B1 (en) Composition for prevention or treatment of dental disease comprising gardenoside

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E601 Decision to refuse application